Loading…

Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder

We report two cases of neuromyelitis optica spectrum disorder (NMOSD) who were misdiagnosed as multiple sclerosis (MS) and developed catastrophic relapses following initiation of dimethyl fumarate. Both patients developed a severe myelitis extending from the cervical cord to the medulla with signifi...

Full description

Saved in:
Bibliographic Details
Published in:Multiple sclerosis 2017-08, Vol.23 (9), p.1297-1300
Main Authors: Yamout, Bassem I, Beaini, Shawkat, Zeineddine, Maya M, Akkawi, Nabil
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c477t-6e5cbc27bd722795f9b6c843bbdf035dba248658f270b273be41735a9a4f40e53
cites cdi_FETCH-LOGICAL-c477t-6e5cbc27bd722795f9b6c843bbdf035dba248658f270b273be41735a9a4f40e53
container_end_page 1300
container_issue 9
container_start_page 1297
container_title Multiple sclerosis
container_volume 23
creator Yamout, Bassem I
Beaini, Shawkat
Zeineddine, Maya M
Akkawi, Nabil
description We report two cases of neuromyelitis optica spectrum disorder (NMOSD) who were misdiagnosed as multiple sclerosis (MS) and developed catastrophic relapses following initiation of dimethyl fumarate. Both patients developed a severe myelitis extending from the cervical cord to the medulla with significant cord swelling, resulting in complete quadriplegia and respiratory difficulties, in addition to severe bilateral visual loss in one patient. It is of note that both catastrophic relapses occurred 2 and 3 months following initiation of dimethyl fumarate.
doi_str_mv 10.1177/1352458517694086
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1886345943</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1352458517694086</sage_id><sourcerecordid>1886345943</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-6e5cbc27bd722795f9b6c843bbdf035dba248658f270b273be41735a9a4f40e53</originalsourceid><addsrcrecordid>eNp1kM1LxDAUxIMoft89SY5eqkmTNO1RFr9A8KLnkqQvu1napiYpy-I_b2TVg-DpPZjfDMwgdEHJNaVS3lAmSi5qQWXVcFJXe-iYcikL0kiyn_8sF1_6ETqJcU0IkZKJQ3RU1qyhkpNj9LFQScUU_LRyBgfo1RQhYuv73m_cuMRudMmp5PyIvcWdGyCttj2286CCSpB1nDYeTxmBMUW8cWmFR5iDH7bQZ2_EfkrOKBwnMCnMQw6JPnQQztCBVX2E8-97it7u714Xj8Xzy8PT4va5MLlLKioQRptS6k6WpWyEbXRlas607ixhotOq5HUlaltKokvJNHCaa6pGccsJCHaKrna5U_DvM8TUDi4a6Hs1gp9jS-u6Ylw0nGWU7FATfIwBbDsFl5tuW0rar8nbv5Nny-V3-qwH6H4NPxtnoNgBUS2hXfs5jLnt_4Gf_USMOQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1886345943</pqid></control><display><type>article</type><title>Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder</title><source>Sage Journals Online</source><creator>Yamout, Bassem I ; Beaini, Shawkat ; Zeineddine, Maya M ; Akkawi, Nabil</creator><creatorcontrib>Yamout, Bassem I ; Beaini, Shawkat ; Zeineddine, Maya M ; Akkawi, Nabil</creatorcontrib><description>We report two cases of neuromyelitis optica spectrum disorder (NMOSD) who were misdiagnosed as multiple sclerosis (MS) and developed catastrophic relapses following initiation of dimethyl fumarate. Both patients developed a severe myelitis extending from the cervical cord to the medulla with significant cord swelling, resulting in complete quadriplegia and respiratory difficulties, in addition to severe bilateral visual loss in one patient. It is of note that both catastrophic relapses occurred 2 and 3 months following initiation of dimethyl fumarate.</description><identifier>ISSN: 1352-4585</identifier><identifier>EISSN: 1477-0970</identifier><identifier>DOI: 10.1177/1352458517694086</identifier><identifier>PMID: 28391740</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adult ; Blindness - chemically induced ; Diagnostic Errors ; Dimethyl Fumarate - adverse effects ; Fatal Outcome ; Female ; Humans ; Immunosuppressive Agents - adverse effects ; Middle Aged ; Multiple Sclerosis - diagnosis ; Multiple Sclerosis - drug therapy ; Myelitis - chemically induced ; Neuromyelitis Optica - diagnosis ; Neuromyelitis Optica - drug therapy ; Quadriplegia - chemically induced ; Recurrence</subject><ispartof>Multiple sclerosis, 2017-08, Vol.23 (9), p.1297-1300</ispartof><rights>The Author(s), 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-6e5cbc27bd722795f9b6c843bbdf035dba248658f270b273be41735a9a4f40e53</citedby><cites>FETCH-LOGICAL-c477t-6e5cbc27bd722795f9b6c843bbdf035dba248658f270b273be41735a9a4f40e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28391740$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamout, Bassem I</creatorcontrib><creatorcontrib>Beaini, Shawkat</creatorcontrib><creatorcontrib>Zeineddine, Maya M</creatorcontrib><creatorcontrib>Akkawi, Nabil</creatorcontrib><title>Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder</title><title>Multiple sclerosis</title><addtitle>Mult Scler</addtitle><description>We report two cases of neuromyelitis optica spectrum disorder (NMOSD) who were misdiagnosed as multiple sclerosis (MS) and developed catastrophic relapses following initiation of dimethyl fumarate. Both patients developed a severe myelitis extending from the cervical cord to the medulla with significant cord swelling, resulting in complete quadriplegia and respiratory difficulties, in addition to severe bilateral visual loss in one patient. It is of note that both catastrophic relapses occurred 2 and 3 months following initiation of dimethyl fumarate.</description><subject>Adult</subject><subject>Blindness - chemically induced</subject><subject>Diagnostic Errors</subject><subject>Dimethyl Fumarate - adverse effects</subject><subject>Fatal Outcome</subject><subject>Female</subject><subject>Humans</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Middle Aged</subject><subject>Multiple Sclerosis - diagnosis</subject><subject>Multiple Sclerosis - drug therapy</subject><subject>Myelitis - chemically induced</subject><subject>Neuromyelitis Optica - diagnosis</subject><subject>Neuromyelitis Optica - drug therapy</subject><subject>Quadriplegia - chemically induced</subject><subject>Recurrence</subject><issn>1352-4585</issn><issn>1477-0970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kM1LxDAUxIMoft89SY5eqkmTNO1RFr9A8KLnkqQvu1napiYpy-I_b2TVg-DpPZjfDMwgdEHJNaVS3lAmSi5qQWXVcFJXe-iYcikL0kiyn_8sF1_6ETqJcU0IkZKJQ3RU1qyhkpNj9LFQScUU_LRyBgfo1RQhYuv73m_cuMRudMmp5PyIvcWdGyCttj2286CCSpB1nDYeTxmBMUW8cWmFR5iDH7bQZ2_EfkrOKBwnMCnMQw6JPnQQztCBVX2E8-97it7u714Xj8Xzy8PT4va5MLlLKioQRptS6k6WpWyEbXRlas607ixhotOq5HUlaltKokvJNHCaa6pGccsJCHaKrna5U_DvM8TUDi4a6Hs1gp9jS-u6Ylw0nGWU7FATfIwBbDsFl5tuW0rar8nbv5Nny-V3-qwH6H4NPxtnoNgBUS2hXfs5jLnt_4Gf_USMOQ</recordid><startdate>201708</startdate><enddate>201708</enddate><creator>Yamout, Bassem I</creator><creator>Beaini, Shawkat</creator><creator>Zeineddine, Maya M</creator><creator>Akkawi, Nabil</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201708</creationdate><title>Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder</title><author>Yamout, Bassem I ; Beaini, Shawkat ; Zeineddine, Maya M ; Akkawi, Nabil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-6e5cbc27bd722795f9b6c843bbdf035dba248658f270b273be41735a9a4f40e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Blindness - chemically induced</topic><topic>Diagnostic Errors</topic><topic>Dimethyl Fumarate - adverse effects</topic><topic>Fatal Outcome</topic><topic>Female</topic><topic>Humans</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Middle Aged</topic><topic>Multiple Sclerosis - diagnosis</topic><topic>Multiple Sclerosis - drug therapy</topic><topic>Myelitis - chemically induced</topic><topic>Neuromyelitis Optica - diagnosis</topic><topic>Neuromyelitis Optica - drug therapy</topic><topic>Quadriplegia - chemically induced</topic><topic>Recurrence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamout, Bassem I</creatorcontrib><creatorcontrib>Beaini, Shawkat</creatorcontrib><creatorcontrib>Zeineddine, Maya M</creatorcontrib><creatorcontrib>Akkawi, Nabil</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Multiple sclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamout, Bassem I</au><au>Beaini, Shawkat</au><au>Zeineddine, Maya M</au><au>Akkawi, Nabil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder</atitle><jtitle>Multiple sclerosis</jtitle><addtitle>Mult Scler</addtitle><date>2017-08</date><risdate>2017</risdate><volume>23</volume><issue>9</issue><spage>1297</spage><epage>1300</epage><pages>1297-1300</pages><issn>1352-4585</issn><eissn>1477-0970</eissn><abstract>We report two cases of neuromyelitis optica spectrum disorder (NMOSD) who were misdiagnosed as multiple sclerosis (MS) and developed catastrophic relapses following initiation of dimethyl fumarate. Both patients developed a severe myelitis extending from the cervical cord to the medulla with significant cord swelling, resulting in complete quadriplegia and respiratory difficulties, in addition to severe bilateral visual loss in one patient. It is of note that both catastrophic relapses occurred 2 and 3 months following initiation of dimethyl fumarate.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>28391740</pmid><doi>10.1177/1352458517694086</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1352-4585
ispartof Multiple sclerosis, 2017-08, Vol.23 (9), p.1297-1300
issn 1352-4585
1477-0970
language eng
recordid cdi_proquest_miscellaneous_1886345943
source Sage Journals Online
subjects Adult
Blindness - chemically induced
Diagnostic Errors
Dimethyl Fumarate - adverse effects
Fatal Outcome
Female
Humans
Immunosuppressive Agents - adverse effects
Middle Aged
Multiple Sclerosis - diagnosis
Multiple Sclerosis - drug therapy
Myelitis - chemically induced
Neuromyelitis Optica - diagnosis
Neuromyelitis Optica - drug therapy
Quadriplegia - chemically induced
Recurrence
title Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A26%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Catastrophic%20relapses%20following%20initiation%20of%20dimethyl%20fumarate%20in%20two%20patients%20with%20neuromyelitis%20optica%20spectrum%20disorder&rft.jtitle=Multiple%20sclerosis&rft.au=Yamout,%20Bassem%20I&rft.date=2017-08&rft.volume=23&rft.issue=9&rft.spage=1297&rft.epage=1300&rft.pages=1297-1300&rft.issn=1352-4585&rft.eissn=1477-0970&rft_id=info:doi/10.1177/1352458517694086&rft_dat=%3Cproquest_cross%3E1886345943%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c477t-6e5cbc27bd722795f9b6c843bbdf035dba248658f270b273be41735a9a4f40e53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1886345943&rft_id=info:pmid/28391740&rft_sage_id=10.1177_1352458517694086&rfr_iscdi=true